- Home
- RGS vs BOLD Comparison
RGS vs BOLD Comparison
Compare RGS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- BOLD
- Stock Information
- Founded
- RGS 1922
- BOLD 2018
- Country
- RGS United States
- BOLD United States
- Employees
- RGS N/A
- BOLD N/A
- Industry
- RGS Other Consumer Services
- BOLD
- Sector
- RGS Consumer Discretionary
- BOLD
- Exchange
- RGS Nasdaq
- BOLD Nasdaq
- Market Cap
- RGS 70.8M
- BOLD 24.4M
- IPO Year
- RGS 1991
- BOLD 2024
- Fundamental
- Price
- RGS $28.47
- BOLD $1.14
- Analyst Decision
- RGS
- BOLD Buy
- Analyst Count
- RGS 0
- BOLD 4
- Target Price
- RGS N/A
- BOLD $4.00
- AVG Volume (30 Days)
- RGS 25.8K
- BOLD 66.0K
- Earning Date
- RGS 11-05-2025
- BOLD 11-06-2025
- Dividend Yield
- RGS N/A
- BOLD N/A
- EPS Growth
- RGS 20.23
- BOLD N/A
- EPS
- RGS 46.10
- BOLD N/A
- Revenue
- RGS $210,134,000.00
- BOLD N/A
- Revenue This Year
- RGS N/A
- BOLD N/A
- Revenue Next Year
- RGS N/A
- BOLD N/A
- P/E Ratio
- RGS $0.65
- BOLD N/A
- Revenue Growth
- RGS 3.52
- BOLD N/A
- 52 Week Low
- RGS $15.00
- BOLD $1.00
- 52 Week High
- RGS $30.29
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- RGS 70.53
- BOLD 47.21
- Support Level
- RGS $27.50
- BOLD $1.13
- Resistance Level
- RGS $30.29
- BOLD $1.19
- Average True Range (ATR)
- RGS 1.61
- BOLD 0.04
- MACD
- RGS 0.42
- BOLD 0.00
- Stochastic Oscillator
- RGS 81.10
- BOLD 44.44
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.